AstraZeneca
AZNCF · LONDON
$168.82+$4.87 (+2.97%)TodayMarket closed ·
Prev close $163.95
Who owns AZNCF
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 19.9% of AZNCF’s shares.
- Investor AB3.3%
- Vanguard Capital Management, LLC2.9%
- Capital International Investors2.2%
- Norges Bank Investment Management (NBIM)2.2%
- Next 6 largest institutions9.2%
- All other shareholders80.1%
| Holder | Shares | % of shares |
|---|---|---|
| Investor AB | 51.59M | 3.33% |
| Vanguard Capital Management, LLC | 45.39M | 2.93% |
| Capital International Investors | 34.58M | 2.23% |
| Norges Bank Investment Management (NBIM) | 33.86M | 2.18% |
| Capital World Investors | 30.08M | 1.94% |
| Wellington Management Company, LLP | 28.54M | 1.84% |
| Legal & General Investment Management Ltd. | 25.75M | 1.66% |
| Fidelity Management & Research Company LLC | 21.54M | 1.39% |
| Vanguard Asset Management Ltd | 18.71M | 1.21% |
| PRIMECAP Management Company | 18.10M | 1.17% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Statens Pensjonsfond Utland | 33.84M | 2.18% |
| Vanguard Total International Stock Index Fund | 22.06M | 1.42% |
| American Funds New Perspective Fund | 16.85M | 1.09% |
| Vanguard Developed Markets Index Fund | 14.72M | 0.95% |
| Vanguard PRIMECAP Fund | 11.92M | 0.77% |
Short interest
Settled Jan 30, 2026
- Shares short
- 152.00K
- Days to cover
- 31.89
- % of shares outstanding
- 0.01%
- Average daily volume
- 4.77K
- Change since last report
- −50.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.